ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings
Please join us for the ACC Rockies Chapter Meeting from August 5-7, 2022 at the Hyatt Centric in Park City, Utah. For more information and to register, please visit: https://cvent.me/zaKr2z
Latest in Cardiology from ACC.org
- Eagleâ€™s Eye View: Why are Women at a Dramatically Lower Risk of Sudden Cardiac Arrest During Sports Compared to Men?In this weekâ€™s View, Dr. Eagle discusses the incidence of cardiac arrest during sports among women versus men, then looks at a scientific statement from the American Heart Association on atrial fibrillation occurring during acute hospitalization.
- Randomized Comparison of Efficacy and Safety of Lipid Lowering With Statin Monotherapy Versus Statin-Ezetimibe Combination for High-Risk Cardiovascular DiseaseThe goal of the RACING trial was to compare the clinical efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients at very high risk for cardiovascular diseases.
- Exercise-Induced Left Atrial Hypertension in HFpEFBased on the REDUCE LAP-HF II trial, in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF or HFpEF), what is the difference between those with normal resting left atrial (LA) pressures but exercise-induced LA hypertension (EILAH) compared to those with resting LA hypertension (RELAH)? How do outcomes differ in these groups […]
- ALT FLOW: APTURE Transcatheter Shunt System Found Safe in Symptomatic HF PatientsLeft atrial to coronary sinus shunting using the APTURE transcatheter shunt system was found to be safe in patients with symptomatic heart failure (HF), resulting in reduction in pulmonary capillary wedge pressure (PCWP) as well as improvement in HF symptoms and quality of life, according to findings from the ALT FLOW Early Feasibility Study, a […]
- Outcomes of Culprit Lesion PCI in Cardiogenic Shock After Cardiac ArrestWhat are the characteristics and outcomes of culprit lesion percutaneous coronary intervention (PCI) of patients with infarct-related cardiogenic shock (CS) stratified by cardiac arrest (CA) in the CULPRIT-SHOCK randomized trial and registry?